Jerome H Kim

InstitutionInternational Vaccine Institute
AddressSeoul
South Korea
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 2 publications in April 2021
    All Publications
    Bar chart showing 188 publications over 18 distinct years, with a maximum of 30 publications in 2014 and 2015
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hotez PJ, Batista C, Amor YB, Ergonul O, Figueroa JP, Gilbert S, Gursel M, Hassanain M, Kang G, Kaslow DC, Kim JH, Lall B, Larson H, Naniche D, Sheahan T, Shoham S, Wilder-Smith A, Sow SO, Strub-Wourgaft N, Yadav P, Bottazzi ME. Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic. EClinicalMedicine. 2021 Sep; 39:101053. PMID: 34368661.
      Citations: 2     
    2. Naniche D, Hotez P, Bottazzi ME, Ergonul O, Figueroa JP, Gilbert S, Gursel M, Hassanain M, Kang G, Kaslow D, Kim JH, Lall B, Larson H, Sheahan T, Shoham S, Wilder-Smith A, Sow SO, Strub-Wourgaft N, Yadav P, Batista C. Beyond the jab: A need for global coordination of pharmacovigilance for COVID-19 vaccine deployment. EClinicalMedicine. 2021 Jun; 36:100925. PMID: 34099998.
      Citations: 1     
    3. Batista C, Shoham S, Ergonul O, Hotez P, Bottazzi ME, Figueroa JP, Gilbert S, Gursel M, Hassanain M, Kang G, Kaslow D, Kim JH, Lall B, Larson H, Naniche D, Sheahan T, Wilder-Smith A, Sow SO, Yadav P, Strub-Wourgaft N. Urgent needs to accelerate the race for COVID-19 therapeutics. EClinicalMedicine. 2021 Jun; 36:100911. PMID: 34036254.
      Citations: 1     
    4. Excler JL, Saville M, Berkley S, Kim JH. Vaccine development for emerging infectious diseases. Nat Med. 2021 04; 27(4):591-600. PMID: 33846611.
      Citations: 15     Fields:    Translation:Humans
    5. Excler JL, Privor-Dumm L, Kim JH. Supply and delivery of vaccines for global health. Curr Opin Immunol. 2021 08; 71:13-20. PMID: 33845349.
      Citations: 4     Fields:    Translation:Humans
    6. Hotez P, Batista C, Ergonul O, Figueroa JP, Gilbert S, Gursel M, Hassanain M, Kang G, Kim JH, Lall B, Larson H, Naniche D, Sheahan T, Shoham S, Wilder-Smith A, Strub-Wourgaft N, Yadav P, Bottazzi ME. Correcting COVID-19 vaccine misinformation: Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members. EClinicalMedicine. 2021 Mar; 33:100780. PMID: 33718854.
      Citations: 7     
    7. Kim JH, Marks F, Clemens JD. Looking beyond COVID-19 vaccine phase 3 trials. Nat Med. 2021 02; 27(2):205-211. PMID: 33469205.
      Citations: 109     Fields:    Translation:HumansPHPublic Health
    8. Kim JH. SARS-CoV-2 vaccine development, access, and equity. J Exp Med. 2020 11 02; 217(11). PMID: 33064151.
      Citations: 4     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    9. Zellweger RM, Wartel TA, Marks F, Song M, Kim JH. Vaccination against SARS-CoV-2 and disease enhancement - knowns and unknowns. Expert Rev Vaccines. 2020 08; 19(8):691-698. PMID: 32838605.
      Citations: 5     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    10. Modjarrad K, Kim JH. Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines? Lancet Infect Dis. 2020 07; 20(7):760-761. PMID: 32325036.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    11. Yoon IK, Kim JH. First clinical trial of a MERS coronavirus DNA vaccine. Lancet Infect Dis. 2019 09; 19(9):924-925. PMID: 31351923.
      Citations: 6     Fields:    Translation:HumansCells
    12. Cho H, Excler JL, Kim JH, Yoon IK. Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges. Hum Vaccin Immunother. 2018 02 01; 14(2):304-313. PMID: 29048984.
      Citations: 11     Fields:    Translation:HumansCells
    13. Excler JL, Delvecchio CJ, Wiley RE, Williams M, Yoon IK, Modjarrad K, Boujelal M, Moorthy VS, Hersi AS, Kim JH. Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015. Emerg Infect Dis. 2016 08; 22(8). PMID: 27439020.
      Citations: 10     Fields:    Translation:HumansAnimalsCells